← Back to Search

Telehealth Mental Health Support for Developmental Disabilities

N/A
Recruiting
Led By Joan B Beasley, PhD
Research Sponsored by University of New Hampshire
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant age 12-45 years
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in feis scores [at 2 timepoints: enrollment, and 1 year (or discharge)]
Awards & highlights
No Placebo-Only Group

Summary

This trial will study if telemental health services can improve access to mental health care for those with intellectual and developmental disabilities, helping to address the disparity in care.

Who is the study for?
This trial is for young individuals aged 14-35 with intellectual and developmental disabilities who live at home with family. They must be new enrollees in the START program within 90 days of joining, and able to give informed consent.
What is being tested?
The study tests telemental health services versus in-person care within the START model, focusing on crisis prevention and intervention for those with IDD. It includes stakeholder feedback, a randomized control trial, and analysis of outcomes across subpopulations.
What are the potential side effects?
Since this trial involves mental health services rather than medication or medical procedures, traditional side effects are not applicable. However, participants may experience varying psychological impacts based on individual responses to telehealth interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 12 and 45 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in feis scores [at 2 timepoints: enrollment, and 1 year (or discharge)]
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in feis scores [at 2 timepoints: enrollment, and 1 year (or discharge)] for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Family Experiences Interview Schedule (FEIS) over 1 year
Secondary study objectives
Change in Aberrant Behavior Checklist (ABC) at 1 year
Change in Crisis Service Use at 1 year
Change in mental health stability as measured by START Plan scores at 1 year
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Telemental health STARTExperimental Treatment4 Interventions
Telemental health START will deliver two components via telephonic or other communication technology (e.g., Zoom). This includes component #2 (consultation and coping skills coaching) and component #4 (service linkages, referrals, outreach, \& training). START components #1 (intake and quarterly assessment) and #3 (24-hour urgent crisis response and intervention) will continue to be provided in-person.
Group II: In-person STARTActive Control4 Interventions
In-person START will deliver all model components in-person. This is the established model.

Find a Location

Who is running the clinical trial?

University of FloridaOTHER
1,403 Previous Clinical Trials
763,863 Total Patients Enrolled
University of New HampshireLead Sponsor
15 Previous Clinical Trials
104,993 Total Patients Enrolled
Georgetown UniversityOTHER
350 Previous Clinical Trials
138,664 Total Patients Enrolled

Media Library

24-hour urgent crisis response and intervention Clinical Trial Eligibility Overview. Trial Name: NCT05336955 — N/A
Developmental Disability Research Study Groups: Telemental health START, In-person START
Developmental Disability Clinical Trial 2023: 24-hour urgent crisis response and intervention Highlights & Side Effects. Trial Name: NCT05336955 — N/A
24-hour urgent crisis response and intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05336955 — N/A
~214 spots leftby Apr 2026